BridgeMD
Compares treatment options for Borderline Personality Disorder
Official title Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personality Disorder in Germany
ClinicalTrials.gov ID: NCT06018272
What this study is testing
- What it's testing
- Background: Borderline Personality Disorder (BPD) is a serious mental disorder. Mentalization-based treatment (MBT) is one evidence-based treatment for individuals with BPD.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Borderline Personality Disorder
- non-suicidal self injury or suicide attempts in the past two years as indicated by the IPDE item "repeated suicidal behaviours, gestures, threats or...
You likely can't join if
- acute substance use disorder (exception: cannabis dependency)
- diagnosis of schizophrenia or schizotypal personality disorder
- bipolar I disorder (DSM-5)
- cognitive impairment (IQ\<80) or evidence of organic brain disorder
- BMI\<16.5
- serious medical condition that will require hospitalization within the next year (e.g. cancer)
See the full eligibility criteria
- Borderline Personality Disorder
- non-suicidal self injury or suicide attempts in the past two years as indicated by the IPDE item "repeated suicidal behaviours, gestures, threats or self-harm", one of which has occurred in the past six months
- acute substance use disorder (exception: cannabis dependency)
- diagnosis of schizophrenia or schizotypal personality disorder
- bipolar I disorder (DSM-5)
- cognitive impairment (IQ\<80) or evidence of organic brain disorder
- BMI\<16.5
- serious medical condition that will require hospitalization within the next year (e.g. cancer)
- no sufficient German language abilities
The study team makes the final eligibility decision.
Where it's taking place
- Berlin, Germany
- Düsseldorf, Germany
- Heidelberg, Germany
- Jena, Germany
- Ulm, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Berlin, Germany; Düsseldorf, Germany; Heidelberg, Germany; Jena, Germany; Ulm, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.